Compare SCI & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCI | PODD |
|---|---|---|
| Founded | 1962 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3B | 10.3B |
| IPO Year | 1994 | 2007 |
| Metric | SCI | PODD |
|---|---|---|
| Price | $82.24 | $163.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 21 |
| Target Price | $98.00 | ★ $341.48 |
| AVG Volume (30 Days) | 1.1M | ★ 1.3M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.57% | N/A |
| EPS Growth | ★ 7.65 | N/A |
| EPS | 0.97 | ★ 1.30 |
| Revenue | ★ $4,309,234,000.00 | $2,708,100,000.00 |
| Revenue This Year | $4.03 | $24.55 |
| Revenue Next Year | $3.73 | $19.18 |
| P/E Ratio | ★ $84.88 | $125.58 |
| Revenue Growth | 2.93 | ★ 30.73 |
| 52 Week Low | $68.41 | $138.79 |
| 52 Week High | $88.67 | $354.88 |
| Indicator | SCI | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 65.33 | 55.69 |
| Support Level | $76.18 | $141.67 |
| Resistance Level | $84.13 | $168.84 |
| Average True Range (ATR) | 1.80 | 5.46 |
| MACD | 0.26 | 0.06 |
| Stochastic Oscillator | 94.40 | 65.67 |
Service Corp International is a personal services company that provides funeral and cemetery services and products from its locations throughout the United States and Canada. The company segments its operations into funeral service and cemetery business functions. At its funeral service locations, Service Corp. provides all professional services, facilities, vehicles, and merchandise related to funerals and cremations. Cemetery locations provide cemetery property, memorial markers, and graveyard services to customers. Service Corp. derives the majority of its revenue from its funeral services segment. Geographically, the company derives a majority of its revenue from the United States.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.